Driving NBRx and Improving AQ: How DeepIntent Outcomes Delivers for Pharma Advertisers
There are more than 20,000 prescription drugs approved for marketing by the Food and Drug Administration (FDA). And yet, they all have one big …
There are more than 20,000 prescription drugs approved for marketing by the Food and Drug Administration (FDA). And yet, they all have one big …
In its true form, convergence refers to the shift from analog to digital, something that’s been happening for many years. By 2022, Leichtman Research …
For decades, traditional or linear TV has dominated the budgets of pharma advertisers. To meet industry recommendations developed decades ago, which call for audience …
Healthcare marketers are looking for deeper, more actionable insights to inform how their campaigns are performing. While clicks and impressions are useful digital metrics …
“My Career Journey” is an interview series where we showcase the phenomenal talent at DeepIntent, offering insight into the paths that led them to …
The data privacy law landscape evolves constantly, which leaves us with two big questions: What does this mean for advertisers? And more importantly, how …
Pharma companies may have been a little slower to embrace connected TV (CTV) advertising than other verticals, but the industry is certainly making up …
For decades, Nielsen was the gold standard that advertisers trusted. Its brand name was — and largely still is — synonymous with linear television …
“My Career Journey” is an interview series where we showcase the phenomenal talent at DeepIntent, offering insight into the paths that led them to …
